Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

22 Biotech Stock Predictions for 2014
TheStreet.com
Mon, 01/6/14 - 09:47 am
Tags:
biotech, Vertex Pharmaceuticals, Orexigen, Retrophin, Valeant Pharmaceuticals, Questcor, Biomarin, Merck, NeoStem, Amgen, Gilead Sciences, Vanda, Keryx, Peregrine Pharmaceuticals, CelSci, Regeneron, Cempra, Dendreon, Clovis Oncology, Halozyme, NPS Pharmaceuticals
3 Health Care Stocks Dragging The Sector Down
TheStreet.com
Fri, 01/3/14 - 12:54 pm
Tags:
Illumina, Alexion, Regeneron
Jim Cramer: Ride the Four Horsemen of Biotech
TheStreet.com
Fri, 12/27/13 - 09:34 am
Tags:
biotech, Biogen Idec, Celgene, Gilead Sciences, Regeneron
How The Global Pharma Industry Will Shape Up In The Next 5 Years?
Seeking Alpha
Wed, 12/4/13 - 11:38 am
Tags:
Bristol-Myers Squibb, GSK, JNJ, Ophthotech, Novartis, Regeneron, Roche, Sanofi
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst
Seeking Alpha
Tue, 12/3/13 - 11:04 am
Tags:
pSivida, ophthalmology, GSK, Novartis, Pfizer, Regeneron, Roche, Sanofi, Iluvien, Durasert, Medidur
Four Biotech 'Surprise' Stocks for 2014
TheStreet.com
Wed, 11/27/13 - 08:34 am
Tags:
Seattle Genetics, Adcetris, Cubist Pharmaceuticals, Cempra, Eylea, Regeneron, Pharmacyclics, Imbruvica, Gilead, sofosbuvir
Ampio Hides Need For New Eye Drug Study in SEC Filing
TheStreet.com
Mon, 11/25/13 - 09:04 am
Tags:
Ampio Pharmaceuticals, SEC, Optina, Regeneron
3 New Cholesterol Treatments Worth Watching
Motley Fool
Sun, 11/24/13 - 12:46 pm
Tags:
Sanofi, Regeneron, Amgen, alirocumab, AMG 145, RN-316, Pfizer
Regeneron's Eylea Approved by Japanese Regulator
Motley Fool
Sat, 11/23/13 - 12:40 pm
Tags:
Regeneron, Eylea, macular edema
The Four Horseman of Pharma
CNBC
Sat, 11/23/13 - 12:36 pm
Tags:
Gilead, Biogen Idec, Celgene, Regeneron
Sanofi Rheumatoid Arthritis Drug Reduces Pain, Damage in Study
Bloomberg
Fri, 11/22/13 - 08:15 am
Tags:
Sanofi, Regeneron, rheumatoid arthritis, Sarilumab
A Shifting Paradigm in Heart Disease Could Affect These Drugmakers
Motley Fool
Mon, 11/18/13 - 10:01 am
Tags:
heart disease, Amgen, statins, Regeneron, Pfizer, Sanofi, PCSK9 inhibitors
FDA says new cholesterol drugs may not need outcome studies
Yahoo/Reuters
Fri, 11/15/13 - 08:37 am
Tags:
FDA, cholesterol, PCSK9 inhibitors, statins, Pfizer, Amgen, Sanofi, Regeneron
U.S. heart guidelines may threaten hot new cholesterol drugs
Yahoo/Reuters
Wed, 11/13/13 - 12:47 pm
Tags:
cholesterol, statins, PCSK9 inhibitors, Sanofi, Regeneron, Pfizer, Amgen
Small Esperion Vs Pharma Giants In The Cholesterol Race
Seeking Alpha
Mon, 11/11/13 - 10:35 am
Tags:
Esperion Therapeutics, ETC-1002, Sanofi, Regeneron, Amgen, Pfizer, Roche
5 Revenue-Growing Biotechs With Attractive Fundamentals
Seeking Alpha
Thu, 11/7/13 - 09:49 am
Tags:
Jazz Pharmaceuticals, Alexion, Questcor, Celgene, Regeneron
Regeneron earnings beat forecasts, Eylea outlook higher
Yahoo/Reuters
Tue, 11/5/13 - 09:35 am
Tags:
earnings, Regeneron
Profit Expected to Dip for Regeneron Pharmaceuticals
Forbes
Fri, 11/1/13 - 11:44 am
Tags:
earnings, Regeneron
The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
Forbes
Fri, 11/1/13 - 08:28 am
Tags:
Pfizer, PCSK9 inhibitors, RN-316, Sanofi, Regeneron, REGN727, AMG145, Amgen
The Next Best Big Pharma?
Seeking Alpha
Tue, 10/22/13 - 11:57 am
Tags:
Regeneron

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.